tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Isofol Medical to Present Q2 2025 Interim Report
Company AnnouncementsIsofol Medical to Present Q2 2025 Interim Report
2d ago
Isofol Medical Announces Change in Shares and Votes
PremiumCompany Announcements
Isofol Medical Announces Change in Shares and Votes
23d ago
Isofol Medical Secures FDA Support for Arfolitixorin Development
PremiumCompany Announcements
Isofol Medical Secures FDA Support for Arfolitixorin Development
1M ago
Isofol Medical’s Rights Issue Fully Subscribed, Boosting Financial Position
PremiumCompany Announcements
Isofol Medical’s Rights Issue Fully Subscribed, Boosting Financial Position
2M ago
Isofol Medical AB Announces Fully Guaranteed Rights Issue
PremiumCompany Announcements
Isofol Medical AB Announces Fully Guaranteed Rights Issue
2M ago
Isofol Medical Advances Arfolitixorin Clinical Study
PremiumCompany AnnouncementsIsofol Medical Advances Arfolitixorin Clinical Study
2M ago
Isofol Medical AB Approves New Share and Warrant Issue to Bolster Financial Position
Premium
Company Announcements
Isofol Medical AB Approves New Share and Warrant Issue to Bolster Financial Position
2M ago
Isofol Medical AB Announces Final Terms for Rights Issue to Fund Expanded Cancer Study
Premium
Company Announcements
Isofol Medical AB Announces Final Terms for Rights Issue to Fund Expanded Cancer Study
3M ago
Isofol Medical Launches New Advisory Board at ASCO 2025
PremiumCompany Announcements
Isofol Medical Launches New Advisory Board at ASCO 2025
3M ago
Isofol Medical Secures FDA Pre-IND Meeting for Arfolitixorin
PremiumCompany Announcements
Isofol Medical Secures FDA Pre-IND Meeting for Arfolitixorin
3M ago
Isofol Medical AB AGM Resolutions and Future Plans
PremiumCompany Announcements
Isofol Medical AB AGM Resolutions and Future Plans
3M ago
Isofol Medical AB Advances Arfolitixorin Development Amid Financial Strategies
PremiumCompany Announcements
Isofol Medical AB Advances Arfolitixorin Development Amid Financial Strategies
3M ago
Isofol Medical Announces Rights Issue to Boost Drug Development
PremiumCompany AnnouncementsIsofol Medical Announces Rights Issue to Boost Drug Development
3M ago
Isofol Medical Secures Financing for Expanded Phase II Study
Premium
Company Announcements
Isofol Medical Secures Financing for Expanded Phase II Study
3M ago
Isofol Medical Initiates Clinical Study for Arfolitixorin in Colorectal Cancer
Premium
Company Announcements
Isofol Medical Initiates Clinical Study for Arfolitixorin in Colorectal Cancer
4M ago
Isofol Medical Initiates Clinical Study for Arfolitixorin in Colorectal Cancer
PremiumCompany Announcements
Isofol Medical Initiates Clinical Study for Arfolitixorin in Colorectal Cancer
4M ago
Isofol Medical Begins Phase Ib/II Study of Arfolitixorin for Colorectal Cancer
PremiumCompany Announcements
Isofol Medical Begins Phase Ib/II Study of Arfolitixorin for Colorectal Cancer
4M ago
Isofol Medical Initiates Clinical Study for Arfolitixorin in Colorectal Cancer
PremiumCompany Announcements
Isofol Medical Initiates Clinical Study for Arfolitixorin in Colorectal Cancer
4M ago
Isofol Medical Begins Phase Ib/II Study of Arfolitixorin for Colorectal Cancer
PremiumCompany Announcements
Isofol Medical Begins Phase Ib/II Study of Arfolitixorin for Colorectal Cancer
4M ago
Isofol Medical Initiates Clinical Study of Arfolitixorin for Colorectal Cancer
PremiumCompany AnnouncementsIsofol Medical Initiates Clinical Study of Arfolitixorin for Colorectal Cancer
4M ago
Isofol Medical Initiates Phase Ib/II Study for Colorectal Cancer Treatment
Premium
Company Announcements
Isofol Medical Initiates Phase Ib/II Study for Colorectal Cancer Treatment
4M ago
Isofol Medical Begins Phase Ib/II Study for Arfolitixorin in Colorectal Cancer
Premium
Company Announcements
Isofol Medical Begins Phase Ib/II Study for Arfolitixorin in Colorectal Cancer
4M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >